PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 26, 20260 citationsOpen Access

SKYVaricella (a live attenuated varicella vaccine) safety issues revisited

View Full Paper
JLJoowon Lee

Key Points

  • The article aims to reassess the safety issues associated with the SKYVaricella vaccine.
  • Review of existing literature on SKYVaricella's safety profile
  • Analysis of adverse effects reported
  • Discussion of immunogenicity and efficacy data
  • Concerns regarding specific safety issues of SKYVaricella noted in past literature
  • Potential adverse effects may influence public perception of the vaccine
  • Recommendations for monitoring and reporting safety events suggested

Abstract

An opinion article regarding SKYVaricella safety issues, accepted by the Ewha Medical Journal (April 20, 2026). This is the accepted version to be published in the Ewha Medical Journal. The final Version of Record will be available via its official DOI once published.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Joowon Lee (2026) studied this question.

synapsesocial.com/papers/6a153a2eb5d9c58d83e8cf1bhttps://doi.org/10.5281/zenodo.20362644
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1SKYVaricella (a live attenuated varicella vaccine) safety issues revisited2026
  2. 2Safety and Immunogenicity of the Live Attenuated Varicella Vaccine in Vietnamese Children Aged 12 Months to 12 Years: An Open-Label, Single-Arm Bridging Study2024 · 1 citations
  3. 3Immunogenicity And Safety Of A Live Attenuated Varicella Vaccine (Oka/Sb Bio) In Healthy Children1996 · 53 citations
  4. 4Perspectives on the History and Epidemiology of the Varicella Virus Vaccine and Future Challenges2025
  5. 5Perspectives on the History and Epidemiology of the Varicella Virus Vaccine and Future Challenges2025